EFG Asset Management »

Intra Cellular Therapies shares owned by EFG Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by EFG Asset Management from 13F filings

Historical chart of EFG Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by EFG Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.2M 74k 83.58
2024-09-30 $2.7M 37k 73.15
2024-06-30 $2.4M 35k 68.42
2024-03-31 $2.4M 34k 69.15
2023-12-31 $2.3M 32k 71.61
2023-09-30 $1.7M 33k 52.07
2023-06-30 $2.0M 32k 63.28
2023-03-31 $1.9M 34k 54.14
2022-12-31 $1.9M 36k 53.54
2022-09-30 $1.7M 37k 46.49
2022-06-30 $2.3M 40k 57.08
2022-03-31 $2.4M 39k 61.20
2021-12-31 $2.0M 39k 52.26

More positions owned by EFG Asset Management

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
Vertiv Holdings Com Cl A (VRT)
Applovin Corp Com Cl A (APP)
Marvell Technology (MRVL)
Arista Networks Com Shs (ANET)
Axon Enterprise (AXON)
Lam Research Corp Com New (LRCX)
Semtech Corporation (SMTC)
Veracyte (VCYT)

View all positions for EFG Asset Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies